Web Analytics

3 Latest Announced Rounds

  • $4,200,000
    Seed

    5 Investors

    Technology, Information and Internet
    Jun 5th, 2025
  • $9,142,230
    Seed

    1 Investors

    Software Development
    Jun 5th, 2025
  • $25,000,000
    Unknown

    2 Investors

    Software Development
    Jun 5th, 2025
$883.17M Raised in 51 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Therini Bio, Inc.

start up
United States - South San Francisco, CA
  • 27/04/2023
  • Series A
  • $36,000,000

Therini Bio, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neuroinflammatory diseases due to vascular dysfunction. Our approach will be generally applicable across a range of inflammatory diseases including peripheral indications. The current therapeutic target is based on novel findings by the Akassoglou lab at Gladstone/UCSF that implicate fibrin as a key driver of neuroinflammation.


Related People

Michael QuigleyFounder

Michael Quigley United States - San Francisco Bay Area

N/A